Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 2025
|
| In: |
European journal of heart failure
Year: 2025, Jahrgang: 27, Heft: 6, Pages: 1028-1046 |
| ISSN: | 1879-0844 |
| DOI: | 10.1002/ejhf.3636 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ejhf.3636 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ejhf.3636 
|
| Verfasserangaben: | Alessandra Ghigo, Pietro Ameri, Aarti Asnani, Edoardo Bertero, Rudolf A. de Boer, Dimitrios Farmakis, Arantxa González, Stephane Heymans, Borja Ibáñez, Teresa López-Fernández, Alexander R. Lyon, Piero Pollesello, Amina Rakisheva, Konstantinos Stellos, Katrin Streckfuss-Bömeke, Carlo Gabriele Tocchetti, Thomas Thum, Peter van der Meer, Eva Van Rooij, Piotr Ponikowski, Marco Metra, Giuseppe Rosano, and Sophie Van Linthout |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1931350507 | ||
| 003 | DE-627 | ||
| 005 | 20250721085649.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250721s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ejhf.3636 |2 doi | |
| 035 | |a (DE-627)1931350507 | ||
| 035 | |a (DE-599)KXP1931350507 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ghigo, Alessandra |e VerfasserIn |0 (DE-588)1371999457 |0 (DE-627)1931351007 |4 aut | |
| 245 | 1 | 0 | |a Update on preclinical models of cancer therapy-related cardiac dysfunction |b Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart |c Alessandra Ghigo, Pietro Ameri, Aarti Asnani, Edoardo Bertero, Rudolf A. de Boer, Dimitrios Farmakis, Arantxa González, Stephane Heymans, Borja Ibáñez, Teresa López-Fernández, Alexander R. Lyon, Piero Pollesello, Amina Rakisheva, Konstantinos Stellos, Katrin Streckfuss-Bömeke, Carlo Gabriele Tocchetti, Thomas Thum, Peter van der Meer, Eva Van Rooij, Piotr Ponikowski, Marco Metra, Giuseppe Rosano, and Sophie Van Linthout |
| 264 | 1 | |c June 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 19 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 11. März 2025 | ||
| 500 | |a Gesehen am 21.07.2025 | ||
| 520 | |a New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the implementation of effective treatments. Therefore, there is a crucial need for appropriate preclinical models to understand the biological basis of their cardiotoxicity. This scientific statement summarizes the preclinical models hitherto used, from in vitro two- and three-dimensional human systems to small and large animals, to pinpoint the molecular mechanisms behind the cardiotoxicity of new-generation anticancer therapies, particularly immunotherapies, and to develop potential cardioprotective strategies. Furthermore, it discusses how preclinical models have contributed to the provocative concept of heart failure being potentially tumorigenic and how the discovery of drugs with both anticancer and cardioprotective actions has revealed a common mechanistic basis for heart failure and cancer. Finally, it discusses the existing gaps between preclinical models and clinical observations in patients, how these discrepancies affect regulatory pathways and the drug development process in cardio-oncology and provides recommendations for closing these gaps. | ||
| 650 | 4 | |a Anticancer therapy | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Cardiotoxicity | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Preclinical models | |
| 700 | 1 | |a Ameri, Pietro |e VerfasserIn |4 aut | |
| 700 | 1 | |a Asnani, Aarti |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bertero, Edoardo |e VerfasserIn |4 aut | |
| 700 | 1 | |a de Boer, Rudolf A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Farmakis, Dimitrios |e VerfasserIn |4 aut | |
| 700 | 1 | |a González, Arantxa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heymans, Stephane |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ibáñez, Borja |e VerfasserIn |4 aut | |
| 700 | 1 | |a López-Fernández, Teresa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lyon, Alexander R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pollesello, Piero |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rakisheva, Amina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stellos, Konstantinos |d 1981- |e VerfasserIn |0 (DE-588)133214354 |0 (DE-627)538682132 |0 (DE-576)272835803 |4 aut | |
| 700 | 1 | |a Streckfuss-Bömeke, Katrin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tocchetti, Carlo Gabriele |e VerfasserIn |4 aut | |
| 700 | 1 | |a Thum, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a van der Meer, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Van Rooij, Eva |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ponikowski, Piotr |e VerfasserIn |4 aut | |
| 700 | 1 | |a Metra, Marco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rosano, Giuseppe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Van Linthout, Sophie |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of heart failure |d Oxford : Wiley, 1999 |g 27(2025), 6, Seite 1028-1046 |h Online-Ressource |w (DE-627)306658291 |w (DE-600)1500332-2 |w (DE-576)081985983 |x 1879-0844 |7 nnas |a Update on preclinical models of cancer therapy-related cardiac dysfunction Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart |
| 773 | 1 | 8 | |g volume:27 |g year:2025 |g number:6 |g pages:1028-1046 |g extent:19 |a Update on preclinical models of cancer therapy-related cardiac dysfunction Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart |
| 856 | 4 | 0 | |u https://doi.org/10.1002/ejhf.3636 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ejhf.3636 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250721 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 133214354 |a Stellos, Konstantinos |m 133214354:Stellos, Konstantinos |d 60000 |d 65000 |e 60000PS133214354 |e 65000PS133214354 |k 0/60000/ |k 1/60000/65000/ |p 14 | ||
| 999 | |a KXP-PPN1931350507 |e 4748222921 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Alessandra","family":"Ghigo","display":"Ghigo, Alessandra","role":"aut"},{"role":"aut","family":"Ameri","display":"Ameri, Pietro","given":"Pietro"},{"role":"aut","family":"Asnani","display":"Asnani, Aarti","given":"Aarti"},{"display":"Bertero, Edoardo","family":"Bertero","role":"aut","given":"Edoardo"},{"role":"aut","family":"de Boer","display":"de Boer, Rudolf A.","given":"Rudolf A."},{"given":"Dimitrios","display":"Farmakis, Dimitrios","family":"Farmakis","role":"aut"},{"role":"aut","family":"González","display":"González, Arantxa","given":"Arantxa"},{"display":"Heymans, Stephane","family":"Heymans","role":"aut","given":"Stephane"},{"given":"Borja","family":"Ibáñez","display":"Ibáñez, Borja","role":"aut"},{"role":"aut","display":"López-Fernández, Teresa","family":"López-Fernández","given":"Teresa"},{"given":"Alexander R.","family":"Lyon","display":"Lyon, Alexander R.","role":"aut"},{"family":"Pollesello","display":"Pollesello, Piero","role":"aut","given":"Piero"},{"role":"aut","display":"Rakisheva, Amina","family":"Rakisheva","given":"Amina"},{"given":"Konstantinos","role":"aut","family":"Stellos","display":"Stellos, Konstantinos"},{"display":"Streckfuss-Bömeke, Katrin","family":"Streckfuss-Bömeke","role":"aut","given":"Katrin"},{"given":"Carlo Gabriele","role":"aut","family":"Tocchetti","display":"Tocchetti, Carlo Gabriele"},{"display":"Thum, Thomas","family":"Thum","role":"aut","given":"Thomas"},{"given":"Peter","display":"van der Meer, Peter","family":"van der Meer","role":"aut"},{"role":"aut","display":"Van Rooij, Eva","family":"Van Rooij","given":"Eva"},{"given":"Piotr","role":"aut","family":"Ponikowski","display":"Ponikowski, Piotr"},{"family":"Metra","display":"Metra, Marco","role":"aut","given":"Marco"},{"role":"aut","display":"Rosano, Giuseppe","family":"Rosano","given":"Giuseppe"},{"display":"Van Linthout, Sophie","family":"Van Linthout","role":"aut","given":"Sophie"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"origin":[{"publisherPlace":"Oxford ; Amsterdam [u.a.] ; Oxford [u.a.] ; Oxford","dateIssuedKey":"1999","dateIssuedDisp":"1999-","publisher":"Oxford University Press ; Elsevier Science ; Oxford Univ. Press ; Wiley"}],"id":{"doi":["10.1002/(ISSN)1879-0844"],"issn":["1879-0844"],"eki":["306658291"],"zdb":["1500332-2"]},"note":["Gesehen am 07.01.25"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"title":[{"subtitle":"journal of the Working Group on Heart Failure of the European Society of Cardiology","title":"European journal of heart failure","title_sort":"European journal of heart failure"}],"titleAlt":[{"title":"EJHF"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"306658291","disp":"Update on preclinical models of cancer therapy-related cardiac dysfunction Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the HeartEuropean journal of heart failure","part":{"text":"27(2025), 6, Seite 1028-1046","extent":"19","issue":"6","year":"2025","pages":"1028-1046","volume":"27"},"pubHistory":["1.1999 -"]}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"June 2025"}],"recId":"1931350507","id":{"eki":["1931350507"],"doi":["10.1002/ejhf.3636"]},"title":[{"title":"Update on preclinical models of cancer therapy-related cardiac dysfunction","subtitle":"Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart","title_sort":"Update on preclinical models of cancer therapy-related cardiac dysfunction"}],"language":["eng"],"physDesc":[{"extent":"19 S.","noteIll":"Illustrationen"}],"note":["Online veröffentlicht: 11. März 2025","Gesehen am 21.07.2025"],"name":{"displayForm":["Alessandra Ghigo, Pietro Ameri, Aarti Asnani, Edoardo Bertero, Rudolf A. de Boer, Dimitrios Farmakis, Arantxa González, Stephane Heymans, Borja Ibáñez, Teresa López-Fernández, Alexander R. Lyon, Piero Pollesello, Amina Rakisheva, Konstantinos Stellos, Katrin Streckfuss-Bömeke, Carlo Gabriele Tocchetti, Thomas Thum, Peter van der Meer, Eva Van Rooij, Piotr Ponikowski, Marco Metra, Giuseppe Rosano, and Sophie Van Linthout"]}} | ||
| SRT | |a GHIGOALESSUPDATEONPR2025 | ||